Anti-aging medicine: Pitfalls and hopes

Aging Male

Volumn 12, Issue 1, 2009, Pages 13-20

  Dominguez, Ligia J ^a   Barbagallo, Mario ^a   Morley, John E ^b,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Anti aging; Hormones; Lifestyle; Physical exercise; Stem cells

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; PRASTERONE; PROGESTERONE; SOMATOMEDIN C; VITAMIN D;

AGING; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; DIET; ESTROGEN THERAPY; EXERCISE; GENETIC DIFFERENCE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIFESTYLE; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; REJUVENATION; REVIEW; SMOKING CESSATION; VITAMIN SUPPLEMENTATION; ANIMAL; CELL AGING; CYTOLOGY; DRUG EFFECT; GERIATRICS; HEALTH BEHAVIOR; LIFE EXPECTANCY; PHYSIOLOGY; QUALITY OF LIFE; STEM CELL;

ANIMALS; CALORIC RESTRICTION; CELL AGING; EXERCISE; GERIATRICS; HEALTH BEHAVIOR; HUMANS; LIFE EXPECTANCY; LIFE STYLE; LONGEVITY; QUALITY OF LIFE; STEM CELLS;

EID: 66149106356     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530902814434     Document Type: Review

References (88)

1. Morley JE. A brief history of geriatrics. J Gerontol A Biol Sci Med Sci 2004;59:1132-1152.
2. Chase P, Mitchell K, Morley JE. In the steps of giants: The early geriatrics texts. J Am Geriatr Soc 2000;48:89-94.
3. Kirkwood TB. A systematic look at an old problem. Nature 2008;451:644-647.
4. Nolte E, Shkolnikov V, McKee M. Changing mortality patterns in East and West Germany and Poland. II: Shortterm trends during transition and in the 1990s. J Epidemiol Community Health 2000;54:899-906. (Pubitemid 30843811)
5. Manton KG, Gu X, Lamb VL. Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population. Proc Natl Acad Sci USA 2006;103:18374-18379.
6. Knoops KT, De Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, Van Staveren WA. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. JAMA 2004;292:1433-1439.
7. Liang H, Masoro EJ, Nelson JF, Strong R, McMahan CA, Richardson A. Genetic mouse models of extended lifespan. Exp Gerontol 2003;38:1353-1364.
8. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 2001;98:6736-6741.
9. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: Longevity, cancer, immunity and lifetime energy intake. J Nutr 1986;116:641-654.
10. Shanley DP, Kirkwood TB. Caloric restriction does not enhance longevity in all species and is unlikely to do so in humans. Biogerontology 2006;7:165-168.
11. Trichopoulou A, Orfanos P, Norat T, Bueno-De-Mesquita B, Ocke MC, Peeters PH, Van Der Schouw YT, Boeing H, Hoffmann K, Boffetta P, et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005;330:991.
12. Trichopoulou A, Bamia C, Trichopoulos D. Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch Intern Med 2005;165:929-935.
13. Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, Visser M, Tylavsky F, Bauer DC, Goodpaster BH, Harris TB. Daily activity energy expenditure and mortality among older adults. JAMA 2006;296:171-179.
14. Ferris DP, Sawicki GS, Daley MA. A physiologist's perspective on robotic exoskeletons for human locomotion. Int J HR 2007;4:507-528.
15. Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet 1989;1:481-483.
16. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
17. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: Interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology 2005;146: 851-860.
18. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging 2005;26:929-937.
19. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007;146:104-115.
20. Dong MQ, Venable JD, Au N, Xu T, Park SK, Cociorva D, Johnson JR, Dillin A, Yates JR, 3rd. Quantitative mass spectrometry identifies insulin signaling targets in C elegans. Science 2007;317:660-663.
21. Flatt T, Min KJ, D'Alterio C, Villa-Cuesta E, Cumbers J, Lehmann R, Jones DL, Tatar M. Drosophila germ-line modulation of insulin signaling and lifespan. Proc Natl Acad Sci USA 2008;105:6368-6373.
22. Bartke A, Chandrashekar V, Turyn D, Steger RW, Debeljuk L, Winters TA, Mattison JA, Danilovich NA, Croson W, Wernsing DR, Kopchick JJ. Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knockout mice. Proc Soc Exp Biol Med 1999;222:113-123.
23. Forster MJ, Morris P, Sohal RS. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J 2003;17:690-692.
24. Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev 2005;126:305-307.
25. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008;105:3438-3442.
26. Johnson TE. Caenorhabditis elegans 2007: The premier model for the study of aging. Exp Gerontol 2008;43:1-4.
27. Lipman RD, Smith DE, Bronson RT, Blumberg J. Is late-life caloric restriction beneficial? Aging (Milano) 1995;7:136-139.
28. Ingram DK, Roth GS, Lane MA, Ottinger MA, Zou S, De Cabo R, Mattison JA. The potential for dietary restriction to increase longevity in humans: Extrapolation from monkey studies. Biogerontology 2006;7:143-148.
29. Partridge L, Gems D. Benchmarks for ageing studies. Nature 2007;450:165-167.
30. Fontana L, Klein S. Aging, adiposity, and calorie restriction. JAMA 2007;297:986-994.
31. Morley JE. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007;13:3637-3647.
32. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191-196.
33. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430:686-689.
34. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: Challenges and insights. Nat Rev Genet 2006;7:436-448.
35. Partridge L, Gems D. Mechanisms of ageing: Public or private? Nat Rev Genet 2002;3:165-175.
36. Russell SJ, Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007;8:681-691.
37. Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al- Share Q, Fernstrom M, Rezaei K, Lee SJ, Koch LG, Britton SL. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005;307:418-420.
38. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, Paupard MC, Hall DH, Driscoll M. Stochastic and genetic factors influence tissue-specific decline in ageing C elegans. Nature 2002;419:808-814.
39. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 2007;5:e201.
40. Brunet A, Rando TA. Ageing: From stem to stern. Nature 2007;449:288-291.
41. Lehrke S, Mazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM, Schuleri KH, Chi AS, Gabrielson KL, Hare JM. Aging impairs the beneficial effect of granulocyte colonystimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 2006;99:553-560.
42. Morley JE, Baumgartner RN, Roubenoff R,Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001;137:231-243.
43. Musaro A, Giacinti C, Borsellino G, Dobrowolny G, Pelosi L, Cairns L, Ottolenghi S, Cossu G, Bernardi G, Battistini L, et al. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA 2004;101:1206-1210.
44. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007;8:703-713.
45. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 1992;89:1567-1571.
46. Percheron G, Hogrel JY, Denot-Ledunois S, Fayet G, Forette F, Baulieu EE, Fardeau M, Marini JF. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-yearold individuals on muscle function and cross-sectional area: A double-blind placebo-controlled trial. Arch Intern Med 2003;163:720-727.
47. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000;97:4279-4284.
48. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647-1659.
49. Bhagra S, Nippoldt TB, Nair KS. Dehydroepiandrosterone in adrenal insufficiency and ageing. Curr Opin Endocrinol Diabetes Obes 2008;15:239-243.
50. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737.
51. Morley JE. Should all long-term care residents receive vitamin D? J Am Med Dir Assoc 2007;8:69-70.
52. Morley JE, Kaiser FE, Perry HM, 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46:410-413.
53. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007;116:2694-2701.
54. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008;93:68-75.
55. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006;166:1660-1665.
56. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and causespecific mortality in men. Arch Intern Med 2007;167:1252-1260.
57. Morley JE, Melmed S. Gonadal dysfunction in systemic disorders. Metabolism 1979;28:1051-1073.
58. Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM. Testosterone use in men with sexual dysfunction: A systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007;82:20-28. (Pubitemid 46036318)
59. Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: Results of a meta-analysis. Clin Endocrinol (Oxf) 2005;63:381-394.
60. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004;89:503-510.
61. Morley JE, Perry HM, 3rd. Androgens and women at the menopause and beyond. J Gerontol A Biol Sci Med Sci 2003;58:M409-M416.
62. Morley JE, Thomas DR. Cachexia: New advances in the management of wasting diseases. J Am Med Dir Assoc 2008;9:205-210.
63. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005;8:56-58.
64. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al. Consensus statement. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, EUA, EAA, and ASA recommendations. Aging Male, in press.
65. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA 1998;280:605-613.
66. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-333.
67. Clarke SC, Kelleher, Lloyd-Jones H, Slack M, Schofield PM. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: The Papworth HRT atherosclerosis study. BJOG 2002;109:1056-1062.
68. ESPRIT Team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: A randomised controlled trial. Lancet 2002;359:2001-2008.
69. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, et al. Estrogen and progesterone use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008;15: 584-603.
70. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005;60:1451-1457.
71. Yates LB, Djousse L, Kurth T, Buring JE, Gaziano JM. Exceptional longevity in men: Modifiable factors associated with survival and function to age 90 years. Arch Intern Med 2008;168:284-290.
72. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: The EPIC-Norfolk prospective population study. PLoS Med 2008;5:e12.
73. Fries JF. Measuring and monitoring success in compressing morbidity. Ann Intern Med 2003;139:455-459.
74. Pahor M, Blair SN, Espeland M, Fielding R, Gill TM, Guralnik JM, Hadley EC, King AC, Kritchevsky SB, Maraldi C, et al. Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for elders pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci 2006;61:1157-1165.
75. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW,Mackenbach JP. The polymeal: A more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004;329: 1447-1450.
76. Knoops KT, Groot De LC, Fidanza F, Alberti-Fidanza A, Kromhout D, Van Staveren WA. Comparison of three different dietary scores in relation to 10-year mortality in elderly European subjects: The HALE project. Eur J Clin Nutr 2006;60:746-755.
77. Trichopoulou A. Traditional Mediterranean diet and longevity in the elderly: A review. Public Health Nutr 2004;7:943-947.
78. Rimm EB, Stampfer MJ. Diet, lifestyle, and longevity - the next steps? JAMA 2004;292:1490-1492.
79. Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European prospective investigation into cancer and nutrition (EPIC) study. Am J Clin Nutr 2004;80:1012-1018.
80. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599-2608.
81. Covas MI, Marrugat J, Fito M, Elosua R, de la Torre-Boronat C. Scientific aspects that justify the benefits of the Mediterranean diet: Mild-to-moderate versus heavy drinking. Ann N Y Acad Sci 2002;957:162-173.
82. Hu FB. The Mediterranean diet and mortality - olive oil and beyond. N Engl J Med 2003;348:2595-2596.
83. Kok FJ, Kromhout D. Atherosclerosis - epidemiological studies on the health effects of a Mediterranean diet. Eur J Nutr 2004; 43(Suppl. 1):I/2-I/5.
84. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004;292: 1440-1446.
85. Kris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL. AHA science advisory: Lyon diet heart study. Benefits of a Mediterranean-style, national cholesterol education program/American heart association step I dietary pattern on cardiovascular disease. Circulation 2001;103: 1823-1825.
86. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: Meta-analysis. BMJ 2008;337:a1344.
87. Rattan SI. The science of healthy aging: Genes, milieu, and chance. Ann NY Acad Sci 2007;1114:1-10.
88. Swift J. Travels into several remote nations of the world. London: Lemuel Gulliver; 1931.